Arimidex Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials

A Trial of Early Detection of Molecular Relapse With Circulating Tumour DNA Tracking and Treatment With Palbociclib Plus Fulvestrant Versus Standard Endocrine Therapy in Patients With ER Positive HER2 Negative Breast Cancer
Conditions:   ER+ Breast Cancer;   HER2-negative Breast Cancer Interventions:   Drug: Palbociclib 125Mg Tab;   Drug: Fulvestrant injection;   Drug: Tamoxifen;   Drug: Letrozole;   Drug: Exemestane;   Drug: Anastrozole Sponsors:   Royal Marsden NHS Foundation Trust;   Pfizer;   AstraZeneca;   Institute of Cancer Research, United Kingdom;   UNICANCER;   Gustave Roussy, Cancer Campus, Grand Paris Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 2, 2021 Category: Research Source Type: clinical trials